<DOC>
	<DOCNO>NCT00128115</DOCNO>
	<brief_summary>The purpose study demonstrate improvement physical functional recovery , follow administration Drug 24 week , patient recently experience hip fracture . This study also evaluate safety tolerability Drug . This early phase trial specific protocol information proprietary publicly available time . ( Full information available trial participant ) .</brief_summary>
	<brief_title>Treatment Sarcopenia Post-Hip Fracture Patients ( 0677-032 )</brief_title>
	<detailed_description />
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Hip Fractures</mesh_term>
	<criteria>Patient surgery unilateral hip fracture , consider partially fully weight bearing surgery Surgical repair fracture occur 4 day post hip fracture Prior start study medication , patient enrol rehabilitation program ( inpatient outpatient ) Patient judge able ambulate independently home prior hip fracture ( able walk indoors familiar set little aid another person ) Patient unstable medical condition Patient hip fracture due bone pathology osteoporosis ( e.g. , malignancy , Paget 's Disease ) , major trauma ( e.g . motor vehicle accident ) . Patient Type I diabetes Patient Type II diabetes condition ; 1 . Patient currently take one antihyperglycemic agent , take single combination antihyperglycemic drug contain one antihyperglycemic medication 2 . Patient currently receive insulin . Note : A shortterm course insulin required glycemic control post hip fracture surgery exclusionary 3 . Patient diabetic retinopathy 4 . Patient unwilling unable monitor glucose home Patient diagnose neuromuscular neurological disease cause muscle weakness Patient cancer , diagnosis malignancy within last 5 year , except adequately treat basal cell squamous cell skin cancer , adequately treat situ cervical cancer Patient active carpal tunnel syndrome Patient living nursing home prior hip fracture ( Note : Patients live assistedliving facility prior hip fracture eligible enrollment ) Patient permanently wheelchair bound prior hip fracture</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>